treatment for a rare or metabolic disease
Alpha-1 antitrypsin
Replacement therapy for a hereditary deficiency. This molecule appears in 6 of the medicines we have indexed.
Do you need a supplement? No.
No supplement is warranted with this treatment. A varied diet remains the foundation.
Do you also take another treatment?
By the Layer Nutrition editorial teamHow the atlas classifies the 664 molecules
- Class
- treatment for a rare or metabolic disease
- Indexed medicines
- 6
- Our answer
- Nothing to add
- Updated
- October 2026
What this medicine is for
It is a medicine in the “treatment for a rare or metabolic disease” category. This medicine addresses a specific rare or metabolic disease, in a specialised setting.
In practice: Replacement therapy for a hereditary deficiency. It is part of specialised, closely monitored care.
The name on your box may be here.
These names come from the public registers of 32 countries: the ANSM for France, the AEMPS for Spain, the AIFA for Italy, the HPRA for Ireland, Swissmedic for Switzerland, and the European Medicines Agency for the others.
Most widespread
- RESPREEZA
- PROLASTIN
- PROLASPLAN
- PROLASTINA
See all names, country by countryHide the list by country
France3
- ALFALASTIN
- PROLASTIN
- RESPREEZA
Spain3
- PROLASPLAN
- PROLASTINA
- RESPREEZA
One answer out of three.
The atlas gives each molecule one of these three answers. Most call for nothing.
- Our formula31 molecules
- An active ingredient to consider59 molecules
- Nothing to add574 moleculesincluding this one
In the same family
Do you also take another treatment?
Type the name written on the box. The atlas gives you its answer.
For example Panadol, Doliprane or paracetamol.